Examkin

Soru

Zorluk: ZorRheumatology and Immunology

A 24-year-old man presents to the clinic evaluating a 10-month history of insidious-onset lower back pain. He notes that the pain is worst upon awakening, is accompanied by profound stiffness lasting up to two hours, and significantly improves after physical activity. He has no other medical conditions and takes no medications. His vital signs are within normal limits. Physical examination reveals tenderness to palpation over the sacroiliac joints and reduced forward flexion of the lumbar spine (abnormal modified Schober test).

Arrange the following interventions in the correct chronological sequence for the standard diagnostic workup and stepwise medical management of this patient's suspected condition. Assume that initial diagnostic imaging is inconclusive (necessitating a more sensitive modality to confirm the diagnosis) and that the patient later requires escalation of maintenance therapy due to an inadequate clinical response to first-line pharmacotherapy.

  1. 1Obtain plain radiography of the sacroiliac joints
  2. 2Obtain magnetic resonance imaging (MRI) of the sacroiliac joints
  3. 3Initiate continuous scheduled therapy with a nonsteroidal anti-inflammatory drug (NSAID)
  4. 4Initiate biologic therapy with a tumor necrosis factor-alpha (TNF-alpha) inhibitor

Cevap

The correct sequence is to first obtain plain radiography of the sacroiliac joints, followed by MRI of the sacroiliac joints if X-rays are inconclusive. Once diagnosed, the first-line treatment is continuous scheduled NSAID therapy. If NSAIDs fail to provide adequate relief, the next step is escalation to a TNF-alpha inhibitor.
The standard evaluation for suspected axial spondyloarthritis begins with plain radiography of the sacroiliac (SI) joints. Because structural changes take years to develop, X-rays may initially be normal. In cases of high clinical suspicion with negative X-rays, MRI of the SI joints is the next step to detect active inflammation (bone marrow edema). Once the diagnosis is secured, the absolute first-line pharmacologic treatment is a continuous nonsteroidal anti-inflammatory drug (NSAID) trial (along with physical therapy). If the patient remains symptomatic after an adequate trial (e.g., at least two different NSAIDs over 4 weeks), therapy is escalated to a biologic agent, most commonly a tumor necrosis factor (TNF) alpha inhibitor such as adalimumab or etanercept.

Adım Adım Çözüm

1
Identify the suspected diagnosis based on the clinical presentation.
The patient has insidious-onset inflammatory back pain (morning stiffness > 1 hour, improves with activity, young age of onset), strongly suggesting axial spondyloarthritis (ankylosing spondylitis).
Recognizing the classic presentation of inflammatory back pain dictates the specific diagnostic and management algorithm to follow.
2
Determine the initial diagnostic imaging modality.
Plain radiography of the sacroiliac joints should be ordered first.
Plain X-ray is the standard initial imaging test to evaluate for definitive structural changes (e.g., erosions, sclerosis, or joint fusion).
3
Determine the appropriate secondary diagnostic test when initial imaging is inconclusive.
MRI of the sacroiliac joints is ordered next.
Because plain radiographs are often normal early in the disease course, MRI is highly sensitive for detecting active bone marrow edema (early sacroiliitis) and confirming non-radiographic axial spondyloarthritis.
4
Identify the first-line pharmacologic treatment once the diagnosis is confirmed.
Continuous scheduled therapy with an NSAID is initiated.
NSAIDs are the cornerstone of initial medical management for axial spondyloarthritis and must be optimized before considering biologic therapies.
5
Determine the next step in management if first-line therapy is ineffective.
Escalate to a TNF-alpha inhibitor.
Patients with persistently high disease activity despite an adequate trial of continuous NSAIDs should be treated with a biologic agent, such as a TNF-alpha or IL-17 inhibitor.

Anahtar Kavram

The diagnostic and therapeutic stepwise approach to axial spondyloarthritis.
Bu soruyu puanla

Konular

Rheumatology and Immunology

Bu konudan daha fazla soru